October 4th, 2017

Promising New Cancer Drug Tested in Phase 1 Clinical Trial

By msequeira

Olivier Rixe, MD, PhD, played a key role in bringing a new cancer drug to clinical trials. Some New Mexicans were among the first in the world to try the new drug, which was made available through the UNM Cancer Center Phase 1 Clinical Trials program.

View Dr. Rixe's interview in Colton Shone's story on KOB-TV 4:

And read The Daily Lobo story by Madison Spratto.

Tags: clinical trials, phase I study, UNM CC In the News